Leslie R Harrold

15PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesRheumatology and arthritisBiomolecular modelling and designClinical and health psychology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Dec 20, 2024
Effectiveness of tofacitinib versus tumor necrosis factor inhibitors and in those receiving tofacitinib as different lines of therapy in patients with rheumatoid arthritis: results from the United States CorEvitas Rheumatoid Arthritis Registry.

Leslie R Harrold, Clifton O Bingham, Janet E Pope

|Jan 19, 2024
Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive.

Leslie R Harrold, Keith Wittstock, Sheila Kelly

|Sep 20, 2023
A Real-World Effectiveness Study Using a Mobile Application to Evaluate Early Outcomes with Upadacitinib in Rheumatoid Arthritis.

Leslie R Harrold, Patrick Zueger, W Benjamin Nowell

|Feb 07, 2023
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP.

Leslie R Harrold, Keith Wittstock, Sheila Kelly

|Oct 16, 2021
Dr. Kremer et al reply.

Joel M Kremer, George Reed, Dimitrios A Pappas

|May 28, 2021
Association Between Baseline Anti-cyclic Citrullinated Peptide Antibodies and 6-Month Clinical Response Following Abatacept or TNF Inhibitor Treatment: A Real-World Analysis of Biologic-Experienced Patients with RA.

Leslie R Harrold, Joshua Bryson, Thomas Lehman

Pageof 3

Frequent Collaborators

3 joint publications

Joel M Kremer

2 joint publications

Dimitrios A Pappas

2 joint publications

Elliot D Rosenstein

2 joint publications

Sabrina Rebello